p53 mediates PEDF‑induced autophagy in human umbilical vein endothelial cells through sestrin2 signaling

Chen,Tiangui; Li,Tianbo; Wang,Jiangning

doi:10.3892/mmr.2019.10319

p53 mediates PEDF‑induced autophagy in human umbilical vein endothelial cells through sestrin2 signaling

Authors:
- Tiangui Chen
- Tianbo Li
- Jiangning Wang
View Affiliations

Affiliations: Orthopedics Surgery Department, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, P.R. China
Published online on: June 3, 2019 https://doi.org/10.3892/mmr.2019.10319
Pages: 1443-1450
Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Autophagy is a conserved catabolic process by which cytoplasmic components are delivered into lysosomes for degradation. Pigment epithelium‑derived factor (PEDF) has been reported to be associated with autophagy and can induce p53 expression; however, the mechanism relating PEDF with autophagy in endothelial cells remains poorly understood. The present study aimed to investigate the association between the PEDF‑p53‑sestrin pathway and autophagy in human umbilical vein endothelial cells (HUVECs). PEDF‑induced autophagy was examined by fluorescence microscopy and western blot analysis. p53 small interfering (si)RNA and sestrin2 siRNA were constructed and transfected into HUVECs prior to PEDF treatment. The protein expression levels of microtubule‑associated protein light chain 3 (LC3) I, LC3 II and p62 were evaluated by western blot analysis, and the mRNA expression levels of p53 and sestrin2 were determined using reverse transcription‑quantitative polymerase chain reaction analysis. The regulation of mechanistic target of rapamycin (mTOR) was reflected by p70S6 kinase (p70S6K) and eukaryotic translation initiation factor 4E‑binding protein 1 (4E‑BP1) protein expression levels, as determined by western blot analysis. PEDF could induce HUVEC autophagy by sequentially inducing p53 and sestrin2 expression, as observed by fluorescence microscopy and western blot analysis. Conversely, the induction of sestrin2 by PEDF was eliminated by p53 siRNA. In addition, p53 siRNA and sestrin2 siRNA could attenuate PEDF‑induced HUVEC autophagy. Inhibition of mTOR may be the mechanism responsible for PEDF‑induced autophagy; as p70S6K and 4E‑BP1 phosphorylation levels were significantly upregulated in p53 siRNA‑treated and sestrin2 siRNA‑treated groups. The findings of the present study indicated that PEDF may trigger autophagy in HUVECs by inducing p53 and sestrin2 expression, and inhibiting mTOR expression; these findings may contribute to the improved understanding of diseases, including cancer and atherosclerosis.

View Figures

View References

1	Kozin SV, Duda DG, Munn LL and Jain RK: Neovascularization after irradiation: What is the source of newly formed vessels in recurring tumors? J Natl Cancer Inst. 104:899–905. 2012. View Article : Google Scholar : PubMed/NCBI
2	Small DM, Burden RE, Jaworski J, Hegarty SM, Spence S, Burrows JF, McFarlane C, Kissenpfennig A, McCarthy HO, Johnston JA, et al: Cathepsin S from both tumor and tumor-associated cells promote cancer growth and neovascularization. Int J Cancer. 133:2102–2112. 2013. View Article : Google Scholar : PubMed/NCBI
3	Lee S, Wurtzel JG, Singhal SS, Awasthi S and Goldfinger LE: RALBP1/RLIP76 depletion in mice suppresses tumor growth by inhibiting tumor neovascularization. Cancer Res. 72:5165–5173. 2012. View Article : Google Scholar : PubMed/NCBI
4	Yoshida GJ: Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: From pathophysiology to treatment. J Hematol Oncol. 10:672017. View Article : Google Scholar : PubMed/NCBI
5	Stanton MJ, Dutta S, Zhang H, Polavaram NS, Leontovich AA, Hönscheid P, Sinicrope FA, Tindall DJ, Muders MH and Datta K: Autophagy control by the VEGF-c/NRP-2 axis in cancer and its implication for treatment resistance. Cancer Res. 73:1602013. View Article : Google Scholar : PubMed/NCBI
6	Nguyen TM, Subramanian IV, Xiao X, Ghosh G, Nguyen P, Kelekar A and Ramakrishnan S: Endostatin induces autophagy in endothelial cells by modulating Beclin 1 and beta-catenin levels. J Cell Mol Med. 13:3687–3698. 2009. View Article : Google Scholar : PubMed/NCBI
7	Becerra SP and Notario V: The effects of PEDF on cancer biology: Mechanisms of action and therapeutic potential. Nat Rev Cancer. 13:258–271. 2013. View Article : Google Scholar : PubMed/NCBI
8	Elahy M, Baindur-Hudson S, Cruzat VF, Newsholme P and Dass CR: Mechanisms of PEDF-mediated protection against reactive oxygen species damage in diabetic retinopathy and neuropathy. J Endocrinol. 222:R129–R139. 2014. View Article : Google Scholar : PubMed/NCBI
9	Nwani NG, Deguiz ML, Jimenez B, Vinokour E, Dubrovskyi O, Ugolkov A, Mazar AP and Volpert OV: Melanoma cells block PEDF production in fibroblasts to induce the tumor-promoting phenotype of cancer-associated fibroblasts. Cancer Res. 76:2265–2276. 2016. View Article : Google Scholar : PubMed/NCBI
10	Fujimura T, Yamagishi S, Ueda S, Fukami K, Shibata R, Matsumoto Y, Kaida Y, Hayashida A, Koike K, Matsui T, et al: Administration of pigment epithelium-derived factor, (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats. Nephrol Dial Transplant. 24:1397–1406. 2008. View Article : Google Scholar : PubMed/NCBI
11	Zhang H, Wei T, Jiang X, Li Z, Cui H, Pan J, Zhuang W, Sun T, Liu Z, Zhang Z and Dong H: PEDF and 34-mer inhibit angiogenesis in the heart by inducing tip cells apoptosis via up-regulating PPAR-γ to increase surface FasL. Apoptosis. 21:60–68. 2016. View Article : Google Scholar : PubMed/NCBI
12	Gao Q, Zhu X, Chen J, Mao C, Zhang L and Xu Z: Upregulation of P53 promoted G1 arrest and apoptosis in human umbilical cord vein endothelial cells from preeclampsia. J Hypertens. 34:1380–1388. 2016. View Article : Google Scholar : PubMed/NCBI
13	Yang A, Rajeshkumar NV, Wang X, Yabuuchi S, Alexander BM, Chu GC, Von Hoff DD, Maitra A and Kimmelman AC: Kimmelman, Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations. Cancer Discov. 4:905–913. 2014. View Article : Google Scholar : PubMed/NCBI
14	Mrakovcic M and Fröhlich LF: p53-mediated molecular control of autophagy in tumor cells. Biomolecules. 8:E142018. View Article : Google Scholar : PubMed/NCBI
15	Shi J, Xiao H, Li J, Zhang J, Li Y, Zhang J, Wang X, Bai X, Tao K, Hu D and Guan H: Wild-type p53-modulated autophagy and autophagic fibroblast apoptosis inhibit hypertrophic scar formation. Lab Invest. 98:1423–1437. 2018. View Article : Google Scholar : PubMed/NCBI
16	Wang N, Pan W, Zhu M, Zhang M, Hao X, Liang G and Feng Y: Fangchinoline induces autophagic cell death via p53/sestrin2/AMPK signalling in human hepatocellular carcinoma cells. Br J Pharmacol. 164:731–742. 2011. View Article : Google Scholar : PubMed/NCBI
17	Maiuri MC, Malik SA, Morselli E, Kepp O, Criollo A, Mouchel PL, Carnuccio R and Kroemer G: Stimulation of autophagy by the p53 target gene Sestrin2. Cell Cycle. 8:1571–1576. 2009. View Article : Google Scholar : PubMed/NCBI
18	D'Amelio M and Cecconi F: A novel player in the p53-mediated autophagy: Sestrin2. Cell Cycle. 8:14672009.
19	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
20	Ho TC, Chen SL, Yang YC, Liao CL, Cheng HC and Tsao YP: PEDF induces p53-mediated apoptosis through PPAR gamma signaling in human umbilical vein endothelial cells. Cardiovasc Res. 76:213–223. 2007. View Article : Google Scholar : PubMed/NCBI
21	Sumitomo Y, Koya J, Nakazaki K, Kataoka K, Tsuruta-Kishino T, Morita K, Sato T and Kurokawa M: Cytoprotective autophagy maintains leukemia-initiating cells in murine myeloid leukemia. Blood. 128:1614–1624. 2016. View Article : Google Scholar : PubMed/NCBI
22	Miao L, Dong Y, Zhou FB, Chang YL, Suo ZG and Ding HQ: Protective effect of tauroursodeoxycholic acid on the autophagy of nerve cells in rats with acute spinal cord injury. Eur Rev Med Pharmacol Sci. 22:1133–1141. 2018.PubMed/NCBI
23	Chen J, Zhu Y, Zhang W, Peng X, Zhou J, Li F, Han B, Liu X, Ou Y and Yu X: Delphinidin induced protective autophagy via mTOR pathway suppression and AMPK pathway activation in HER-2 positive breast cancer cells. BMC Cancer. 18:3422018. View Article : Google Scholar : PubMed/NCBI
24	Ellis M, Stern O and Ashur-Fabian O: The double benefit of Spalax p53: Surviving underground hypoxia while defying lung cancer cells in vitro via autophagy and caspase-dependent cell death. Oncotarget. 7:63242–63251. 2016. View Article : Google Scholar : PubMed/NCBI
25	Jakhar R, Paul S, Bhardwaj M and Kang SC: Astemizole-Histamine induces Beclin-1-independent autophagy by targeting p53-dependent crosstalk between autophagy and apoptosis. Cancer Lett. 372:89–100. 2015. View Article : Google Scholar : PubMed/NCBI
26	Haque E, Kamil M, Irfan S, Sheikh S, Hasan A, Nazir A and Mir SS: Blocking mutation independent p53 aggregation by emodin modulates autophagic cell death pathway in lung cancer. Int J Biochem Cell Biol. 96:90–95. 2018. View Article : Google Scholar : PubMed/NCBI
27	Liu D, Li R, Guo X, Pang L, Zang Y, Liu K and Chen D: Chen, DNA damage regulated autophagy modulator 1 recovers the function of apoptosis-stimulating of p53 protein 2 on inducing apoptotic cell death in Huh7.5 cells. Oncol Lett. 15:9333–9328. 2018.PubMed/NCBI
28	Zhang QY, Jin R, Zhang X, Sheng JP, Yu F, Tan RX, Pan Y, Huang JJ and Kong LD: The putative oncotarget CSN5 controls a transcription-uncorrelated p53-mediated autophagy implicated in cancer cell survival under curcumin treatment. Oncotarget. 7:69688–69702. 2016.PubMed/NCBI
29	Budanov AV and Karin M: p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell. 134:451–460. 2008. View Article : Google Scholar : PubMed/NCBI
30	Jayaraj P, Sen S, Rangarajan S, Ray N, Vasu K, Singh VK, Phartyal R, Yadav S and Verma A: Immunohistochemical evaluation of stress-responsive protein sestrin2 and its correlation with p53 mutational status in eyelid sebaceous gland carcinoma. Br J Ophthalmol. 102:848–854. 2018. View Article : Google Scholar : PubMed/NCBI
31	Wang N, Zhang Q, Luo L, Ning B and Fang Y: β-asarone inhibited cell growth and promoted autophagy via P53/Bcl-2/Bclin-1 and P53/AMPK/mTOR pathways in Human Glioma U251 cells. J Cell Physiol. 233:2434–2443. 2018. View Article : Google Scholar : PubMed/NCBI
32	Kassem L and Abdel-Rahman O: Targeting mTOR pathway in gynecological malignancies: Biological rationale and systematic review of published data. Crit Rev Oncol Hematol. 108:1–12. 2016. View Article : Google Scholar : PubMed/NCBI
33	Saxton RA and Sabatini DM: mTOR signaling in growth, metabolism, and disease. Cell. 168:960–976. 2017. View Article : Google Scholar : PubMed/NCBI
34	Munson MJ and Ganley IG: MTOR, PIK3C3 and autophagy: Signaling the beginning from the end. Autophagy. 11:2375–2376. 2015. View Article : Google Scholar : PubMed/NCBI